You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ide-cel

Showing 1 - 25 of 288
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in New York (Ide-cel (bb2121))

Recruiting
  • Multiple Myeloma
  • Ide-cel (bb2121)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 6, 2022

Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)

Recruiting
  • Multiple Myeloma
  • BB2121
  • +2 more
  • Birmingham, Alabama
  • +33 more
Jan 26, 2023

Multiple Myeloma Trial in United States (bb2121, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +3 more
  • Scottsdale, Arizona
  • +19 more
Jul 7, 2022

Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)

Not yet recruiting
  • Multiple Myeloma
  • idecabtagene vicleucel
  • +3 more
  • Gilbert, Arizona
  • +107 more
Sep 26, 2023

Multiple Myeloma Trial in United States (Talquetamab)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Sep 27, 2023

CAR-T Retreatment Trial in Shanghai (axi-cel)

Recruiting
  • CAR-T Retreatment
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Mar 23, 2023

Relapsed/Refractory Large B-Cell Lymphoma Trial in Beijing, Hangzhou (Prizloncabtagene autoleucel)

Recruiting
  • Relapsed/Refractory Large B-Cell Lymphoma
  • Prizloncabtagene autoleucel
  • Beijing, China
  • +1 more
Mar 24, 2023

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (Ciltacabtagene Autoleucel, Cyclophosphamide, Fludarabine

Not yet recruiting
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Ciltacabtagene Autoleucel
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 2, 2023

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Diffuse Large B Cell Lymphoma
  • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital
Nov 19, 2023

Lymphoma, Lymphoma Cns Trial in Boston (Fludarabine, Cyclophosphamide, Axicabtagene Ciloleucel)

Recruiting
  • Lymphoma
  • Lymphoma Cns
  • Boston, Massachusetts
  • +1 more
Jan 3, 2023

Multiple Myeloma Trial in Worldwide (Cilta-cel)

Recruiting
  • Multiple Myeloma
  • Phoenix, Arizona
  • +30 more
Aug 11, 2022

Sickle Cell Disease Trial (Exa-cel)

Not yet recruiting
  • Sickle Cell Disease
  • Exa-cel
  • (no location specified)
Jul 14, 2023

Multiple Myeloma Trial (Cilta-cel OOS Therapy)

Available
  • Multiple Myeloma
  • Cilta-cel OOS Therapy
  • (no location specified)
Aug 15, 2022

Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Large B-cell Lymphoma
  • Axicabtagene Ciloleucel
  • Palo Alto, California
    Stanford University
Mar 20, 2023

Multiple Myeloma Trial (Nonconforming idecabtagene vicleucel)

Available
  • Multiple Myeloma
  • Nonconforming idecabtagene vicleucel
  • (no location specified)
Feb 7, 2022

Nurse inMobile Palliative Care Team: Real Autonomy or Utopia

Recruiting
  • Palliative Care
    • Strasbourg, France
      Service de soins Palliatifs - CHU de Strasbourg - France
    Oct 30, 2023

    Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported

    Active, not recruiting
    • Diffuse Large B Cell Lymphoma
    • Transformed Lymphoma
    • Handgrip strength test
    • +9 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 12, 2023

    Systemic Lupus Erythematosus Trial in Shanghai (Relma-cel)

    Recruiting
    • Systemic Lupus Erythematosus
    • Relma-cel
    • Shanghai, China
      Relma-cel Medical
    Mar 12, 2023

    Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome Trial

    Not yet recruiting
    • Recurrent Transformed Chronic Lymphocytic Leukemia
    • +2 more
    • Biopsy
    • +10 more
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)

    Active, not recruiting
    • Multiple Myeloma
    • Birmingham, Alabama
    • +87 more
    Jan 17, 2023

    Rotator Cuff Tears, Muscle Atrophy or Weakness, Tendon Rupture - Shoulder Trial in New York (E-CEL UVEC)

    Active, not recruiting
    • Rotator Cuff Tears
    • +3 more
    • E-CEL UVEC
    • New York, New York
      Hospital for Special Surgery
    Aug 5, 2022

    Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)

    Not yet recruiting
    • Extramedullary Myeloma
    • Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Dec 18, 2022

    Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Itacitinib
    • Chimeric antigen receptor (CAR) T-cell therapy
    • Tampa, Florida
      Moffitt Cancer Center
    Mar 6, 2023

    Multiple Myeloma Trial in United States (Cilta-cel, Lymphodepleting Therapy (Cyclophosphamide and Fludarabine))

    Recruiting
    • Multiple Myeloma
    • Cilta-cel
    • Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
    • Duarte, California
    • +23 more
    Aug 1, 2022

    Real-world Study Optimizing Nucleotide-analogues

    Recruiting
    • Hepatitis B, Chronic
    • Hefei, Anhui, China
    • +43 more
    Jul 7, 2023